Navigation Links
Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting
Date:9/18/2007

DANBURY, Conn., Sept. 18 /PRNewswire-FirstCall/-- Biodel Inc. (Nasdaq: BIOD) today announced additional clinical data from its VIAject(TM) program at the 43rd Scientific Sessions of the European Association for the Study of Diabetes (EASD).

VIAject(TM) Phase II meal study data was disclosed in an oral presentation at EASD entitled, "Pharmacokinetics and pharmacodynamics of insulin VIAject(TM), insulin lispro and regular human insulin when injected subcutaneously immediately before a meal in patients with Type 1 diabetes." The VIAject (TM) Phase II meal study results demonstrated statistically significant and clinically relevant improved glycemic control compared to regular human insulin (Humulin(R) R) and lispro (Humalog(R)).

"We are pleased that VIAject(TM) continues to yield improved pharmacokinetic and pharmacodynamic data when compared to both Humulin(R) R and Humalog(R)," commented Dr. Solomon Steiner, Chairman and CEO of Biodel. "These differences translate into better glycemic control and fewer hypoglycemic events which we continue to track in our ongoing Phase III VIAject(TM) clinical trials."

"The absorption of VIAject(TM), especially after the first 30 minutes, is much more rapid when compared to regular insulin and lispro," elaborated Dr. Lutz Heinemann, CEO of Profil Institute for Metabolic Research in Neuss, Germany. "Improvements in pharmacokinetic and pharmacodynamic parameters may translate into improved postprandial metabolic control, resulting in a safer treatment option for the diabetic population."

In the Phase II meal study of VIAject(TM), subjects received either VIAject(TM), Humulin(R) R (regular recombinant human insulin) or Humalog(R) (rapid acting insulin analog) in conjunction with a standardized meal. Plasma insulin and blood glucose levels were monitored throughout the study. Administration of VIAject(TM) resulted in statistically significantly faster insulin absorption than Humulin(R) R and Humalog(R) and
'/>"/>

SOURCE Biodel Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... , Dec. 22, 2014  Alternative Energy & ... it has signed a letter of intent to ... developed and patented a nanotechnology-based development platform used ... that enable rapid on-site collection and testing to ... health issues in an immediate, non-invasive and cost-effective ...
(Date:12/22/2014)... 22, 2014 ITRA Global, one of ... of commercial real estate, has further expanded its global ... Perth and Brisbane, Western Australia, reports Mylinda Vick, CCIM, ... ITRA Global / ACORPP (Australian Corporate Property and ... company providing property services to a wide range of ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one of the ... Maroulis, Pharm.D. to the newly created position of Vice ... position, Dr. Maroulis will continue to manage the entire ... multi-site pharmacies as the company expands. Dr. Maroulis has ... he has served in many different capacities in the ...
(Date:12/19/2014)... BURLINGTON, Mass. , Dec. 19, 2014 ... biomaterial market will grow at a 12 percent compound ... a result of the aging population and the increasing ... Latin America will also spur demand ... results of dental implant and periodontal treatments. ...
Breaking Biology Technology:ALNE Announces Intention To Acquire BioTechPharma 2ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3
... Biotech Inc. (TSX:,ONC, NASDAQ: ONCY) ("Oncolytics") today announced ... "Reovirus for the Treatment of Neoplasia.",The claims describe ... that,have inactivated PKR, whether the PKR is inactivated ... is a host cellular protein responsible for preventing,virus ...
... Geffen School of Medicine at UCLA and the Howard ... largest cellular particle ever crystallized, suggesting ways to engineer ... The research study, which focuses on new engineered nanomaterial ... the Nov. 27 edition of the peer-reviewed, open-access journal ...
... Largest Ophthalmology Practice Will Assess for Diabetic ... Retinopathy, a Leading Cause of Blindness, WAKE FOREST, ... specializing in retinal risk assessment for diabetics,announced today that Cincinnati ... the Retasure retinal imaging system., CEI is the largest ...
Cached Biology Technology:Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent 2Researchers outline structure of largest nonvirus particle ever crystallized 2Digital Healthcare Announces Cincinnati Eye Institute is Latest Retasure Reading Center 2
(Date:12/11/2014)... 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition ... Region 2015-2019"  report to their offering. ... is advances in technology. With continuous advances in ... to the latest standard that meets the needs ...
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader in ... seeing a staggering demand from its licensees for highly ... revealed, is not solely coming from fitness and health ... "A wearable is only as useful as ... is the ultimate driver in long-term mass consumer adoption ...
(Date:12/5/2014)... MOUNTAIN VIEW, Calif. , Dec. 4, 2014 ... and safety has boosted investments in new testing ... products has also given rise to a range ... driven by the requirements of Generation Y, which ... digital technologies. As a result, product development strategies ...
Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
... limnologist, or lake scientist, John Downing finds that ponds around ... oceans. Professor Downing found that constructed ponds and ... a much higher rate than expected; as much as 20-50 ... ponds were found to take up carbon at a higher ...
... to Feature New Version of PocketCop Software, ... Bulletin Board: BKYI), a leader in finger-based biometric,identification ... will be showcasing its latest mobile data solution ... Information Management,(LEIM) Conference, to be held May 7-9 ...
... Spearhead Effort in Support of "New Employee,Verification Act", ... largest,association devoted to human resource management today led ... endorse the "New Employee,Verification Act." In testimony today ... Security, Sue Meisinger, President and CEO of SHRM,urged ...
Cached Biology News:Ponds found to take up carbon like world's oceans 2BIO-key(R) Showcasing Public Safety Solutions for BlackBerry Smartphones at 2008 LEIM Conference 2BIO-key(R) Showcasing Public Safety Solutions for BlackBerry Smartphones at 2008 LEIM Conference 3SHRM CEO Testifies Before House Subcommittee on Social Security 2SHRM CEO Testifies Before House Subcommittee on Social Security 3
... Immunodetection Kits are designed for ultra-sensitive ... nitrocellulose or PVDF membranes. Since all ... and primary antibodies), the WesternBreeze Kits ... your protocol and getting your final ...
Immunogen: Synthetic peptide: S(399) P W S E L E F Q F P D D K D P V W E F(418) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Human ABCG2 MAb (Clone 5D3)...
Borosilicate Glass. Certified for use with the Beacon 2000 Systems, 1,000 tubes/case...
Biology Products: